Patients who may benefit most include: Adults with type 2 diabetes and hypertension This represents a common clinical scenario where metabolic and cardiovascular risk factors coexist
Understanding Costs Cost is important to consider when deciding what GLP-1 medication to take
It is not licensed by the MHRA or EMA in the UK and is unavailable through NHS prescribing pathways as of 2025
In the SURMOUNT-1 trial, tirzepatide 15 mg weekly achieved 20.9% WL over 72 weeks (vs
Similarly, although medullary thyroid cancer has been linked to GLP-1RAs in rodent studies, there have been very few or no reports of medullary thyroid cancer in clinical trials [4, 9, 67, 68]
After two pregnancies, she found it hard to return to a healthy weight despite rigorous diet and training